View in EDS

Phase II Trial of Afatinib in Patients With EGFR -Mutated Solid Tumors Excluding Lung Cancer: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol A.

Saved in:
Bibliographic Details
Title: Phase II Trial of Afatinib in Patients With EGFR -Mutated Solid Tumors Excluding Lung Cancer: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol A.
Authors: Gettinger, Scott N.1 (AUTHOR) Scott.gettinger@yale.edu, Song, Zihe2 (AUTHOR), Reckamp, Karen L.3 (AUTHOR), Moscow, Jeffrey A.4 (AUTHOR), Gray, Robert J.2 (AUTHOR), Wang, Victoria2 (AUTHOR), McShane, Lisa M.5 (AUTHOR), Rubinstein, Larry V.5 (AUTHOR), Patton, David R.6 (AUTHOR), Williams, P. Mickey7 (AUTHOR), Hamilton, Stanley R.8 (AUTHOR), Kong, Xiao-Tang9 (AUTHOR), Tricoli, James V.10 (AUTHOR), Conley, Barbara A.10 (AUTHOR), Arteaga, Carlos L.11 (AUTHOR), Harris, Lyndsay N.10 (AUTHOR), O'Dwyer, Peter J.12 (AUTHOR), Chen, Alice P.13 (AUTHOR), Flaherty, Keith T.14 (AUTHOR)
Source: JCO Precision Oncology. 12/1/2024, Vol. 8, p1-10. 10p.
Database: Academic Search Ultimate
Description
ISSN:24734284
DOI:10.1200/PO.23.00725